Geraniol
CAS No. 106-24-1
Geraniol( —— )
Catalog No. M20315 CAS No. 106-24-1
geraniol?provides a potent protective effect against cardiac dysfunction induced by diabetes. This ameliorative effect could be attributed to its suppression of oxidative stress.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 41 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGeraniol
-
NoteResearch use only, not for human use.
-
Brief Descriptiongeraniol?provides a potent protective effect against cardiac dysfunction induced by diabetes. This ameliorative effect could be attributed to its suppression of oxidative stress.
-
Descriptiongeraniol?provides a potent protective effect against cardiac dysfunction induced by diabetes. This ameliorative effect could be attributed to its suppression of oxidative stress.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106-24-1
-
Formula Weight154.25
-
Molecular FormulaC10H18O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC\C(C)=C\CC\C(C)=C\CO
-
Chemical Name26-Octadien-1-ol 37-dimethyl- (2E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Bassossy HM Ghaleb H Elberry AA et al. Geraniol alleviates diabetic cardiac complications: Effect on cardiac ischemia and oxidative stress.Biomed Pharmacother[J]. 2017 Apr;88:1025-1030.
molnova catalog
related products
-
Calcium dobesilate
Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG?induced inflammation.
-
5(6)-CFDA
5(6)-CFDA is a cell-permeant esterase substrate that can serve as a viability probe that measures both enzymatic activities.
-
7-Chloro-4-(piperazi...
7-Chloro-4-(piperazin-1-yl)quinolone is an important scaffold in medicinal chemistry, exhibiting diverse pharmacological profiles either alone or as a hybrid with other active pharmacophores.
Cart
sales@molnova.com